RNF168 and ovarian carcinoma: When p62 was transiently knocked down, p62 was decreased in both control and ovarian cancer cells overexpressing LOC730101, while the decreased RNF168 was reverted in ovarian cancer cells overexpressing LOC730101 (Fig. 7F).